Sanofi India has reported results for first quarter ended March 31, 2013.
The company has reported 10.47% rise in its net profit of Rs 44.30 crore for the quarter ended March 31, 2013 as compared to Rs 40.10 crore for the same quarter in the previous year. Total income from operation of the company has increased by 13.35% at Rs 388.10 crore for quarter under review as compared to Rs 342.40 crore for the quarter ended March 31, 2012.
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health.
